Key Clinical Message Patients who received allogeneic haematopoietic stem cell transplantation (allo-HSCT) may develop T cell-mediated immunologic injury to muscles, recapitulating the characteristics of polymyositis clinically and pahtologically. Polymyositis is a rarely reported complication of graft-versus-host disease (GVHD), which often responds well to corticosteroids and immunosuppressive treatment.
第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Neurol,Wuhan 430030,Hubei,Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Meng Lijuan,Ji Suqiong,Wang Qiong,et al.Polymyositis as a manifestation of chronic graft-versus-host disease after allo-HSCT[J].CLINICAL CASE REPORTS.2018,6(9):1723-1726.doi:10.1002/ccr3.1709.
APA：
Meng, Lijuan,Ji, Suqiong,Wang, Qiong&Bu, Bitao.(2018).Polymyositis as a manifestation of chronic graft-versus-host disease after allo-HSCT.CLINICAL CASE REPORTS,6,(9)
MLA：
Meng, Lijuan,et al."Polymyositis as a manifestation of chronic graft-versus-host disease after allo-HSCT".CLINICAL CASE REPORTS 6..9(2018):1723-1726
